Literature DB >> 15128947

Reconstitution of retroviral fusion and uncoating in a cell-free system.

Shakti Narayan1, John A T Young.   

Abstract

The molecular events underlying the immediate steps of retroviral uncoating, occurring after membrane fusion and leading to the formation of an active reverse transcription complex, are not known. To better understand these processes, we have developed a cell-free system that recapitulates these early steps of retroviral replication by using avian sarcoma and leukosis virus as a model retrovirus. The substrates used in this system are viral particles that are trapped before completing membrane fusion. These virions are induced to fuse out of endosomes and the viral cores are released into solution where they are amenable to biochemical manipulation. This system revealed that membrane fusion is not sufficient to stimulate the formation of a reverse transcription complex. Instead, ATP hydrolysis and cellular factors >5 kDa in size are required. Furthermore, later steps of avian sarcoma and leukosis virus reverse transcription were stimulated by nuclear factors. The cell-free system should now allow for the definition of retroviral uncoating mechanisms and facilitate the identification and characterization of the cellular factors involved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128947      PMCID: PMC419673          DOI: 10.1073/pnas.0401312101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 2.  Viral entry into the nucleus.

Authors:  G R Whittaker; M Kann; A Helenius
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

Review 3.  Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways.

Authors:  S P Goff
Journal:  J Gene Med       Date:  2001 Nov-Dec       Impact factor: 4.565

Review 4.  Mechanisms of viral membrane fusion and its inhibition.

Authors:  D M Eckert; P S Kim
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

5.  Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein.

Authors:  S Snitkovsky; T M Niederman; R C Mulligan; J A Young
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants.

Authors:  T M Cairns; R C Craven
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Specific incorporation of heat shock protein 70 family members into primate lentiviral virions.

Authors:  Cagan Gurer; Andrea Cimarelli; Jeremy Luban
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity.

Authors:  Andrew C S Saphire; Michael D Bobardt; Philippe A Gallay
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

9.  Cell type-specific replication of simian virus 40 conferred by hormone response elements in the late promoter.

Authors:  Michael L Farrell; Janet E Mertz
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

View more
  16 in total

1.  In defense of the cell: TRIM5alpha interception of mammalian retroviruses.

Authors:  Kyeongeun Lee; Vineet N KewalRamani
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

2.  How TRIM5alpha defends against retroviral invasions.

Authors:  Michael Emerman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

3.  Visualization of the two-step fusion process of the retrovirus avian sarcoma/leukosis virus by cryo-electron tomography.

Authors:  Giovanni Cardone; Matthew Brecher; Juan Fontana; Dennis C Winkler; Carmen Butan; Judith M White; Alasdair C Steven
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

4.  Reverse transcription complex: the key player of the early phase of HIV replication.

Authors:  Sergey Iordanskiy; Michael Bukrinsky
Journal:  Future Virol       Date:  2007-01-01       Impact factor: 1.831

5.  Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactors.

Authors:  Kylie Warren; Ting Wei; Dongsheng Li; Fangyun Qin; David Warrilow; Min-Hsuan Lin; Haran Sivakumaran; Ann Apolloni; Catherine M Abbott; Alun Jones; Jenny L Anderson; David Harrich
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-24       Impact factor: 11.205

6.  Isolation of cell lines that show novel, murine leukemia virus-specific blocks to early steps of retroviral replication.

Authors:  James W Bruce; Kenneth A Bradley; Paul Ahlquist; John A T Young
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity.

Authors:  Cagan Gurer; Anders Höglund; Stefan Höglund; Jeremy Luban
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Strand transfer and elongation of HIV-1 reverse transcription is facilitated by cell factors in vitro.

Authors:  David Warrilow; Kylie Warren; David Harrich
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

9.  Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating.

Authors:  Richard J O Barnard; Shakti Narayan; Geethanjali Dornadula; Michael D Miller; John A T Young
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitro.

Authors:  David Warrilow; Luke Meredith; Adam Davis; Christopher Burrell; Peng Li; David Harrich
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.